Progyny Inc (PGNY)
Official siteHEALTHCARE • HEALTHCARE PLANS • NASDAQ
Market Cap: $2.74B
Last updated: Nov 17, 2026 at 4:30 PM ET
Progyny Inc (PGNY) Statistics
Progyny (PGNY) has a market cap of $2.74B and an enterprise value of $2.62B. Its share count is down 11.38% from a year earlier.
Total Valuation
Enterprise value is 4.27% below the market cap, as cash exceeds debt.
| Market Cap | $2.74B |
|---|---|
| Enterprise Value | $2.62B |
| Latest price (Nov 17, 2026) | $36.71 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.1x and 6.8x. Its year-end P/E ranged from 10.5x to 353.3x from 2020 to 2025.
| P/E Ratio | 28.5x |
|---|---|
| Forward P/E | 28.0x |
| P/S Ratio | 2.1x |
| Forward P/S | 2.0x |
| P/B Ratio | 6.8x |
| P/TBV Ratio | 7.2x |
| P/FCF Ratio | 15.6x |
| P/OCF Ratio | 13.2x |
| PEG Ratio | 1.0 |
Enterprise Valuation
Counting debt and cash, the company is valued at 19.3x EBITDA and 14.9x free cash flow.
| EV / Earnings | 28.8x |
|---|---|
| EV / Sales | 2.0x |
| EV / EBITDA | 19.3x |
| EV / EBIT | 19.8x |
| EV / FCF | 14.9x |
Price Statistics
The stock is up 49.53% over 52 weeks and trades 27.02% above its 50-day average.
| Beta (1Y) | -0.09 |
|---|---|
| 52-Week Change | +49.53% |
| 1-Month Change | +31.86% |
| 3-Month Change | +43.79% |
| 6-Month Change | +49.23% |
| 5-Year Change | -52.48% |
| Total Return (1Y) | +49.53% |
| Total Return (3Y CAGR) | +4.47% |
| Total Return (5Y CAGR) | -9.15% |
| Return vs SPY (1Y) | +30.45% |
| Max Drawdown (1Y) | -42.65% |
| Max Drawdown (3Y) | -67.16% |
| Sharpe Ratio (1Y) | 0.71 |
| Correlation with SPY (1Y) | -0.03 |
| 50-Day Average | $28.90 |
| 200-Day Average | $24.95 |
| 52-Week Range | $16.10 to $37.20 |
| RSI (14 Days) | 77.8 |
| Average Volume (20 Days) | 1.06M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.93x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.93x |
|---|---|
| Quick Ratio | 1.93x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 21.98% over the last 12 months, against a 5-year average of 13.92%.
| Return on Equity (ROE) | 21.98% |
|---|---|
| Return on Assets (ROA) | 13.47% |
| Return on Capital Employed (ROCE) | 30.36% |
| ROE (5Y Average) | 13.92% |
| ROA (5Y Average) | 9.80% |
| ROIC (5Y Average) | 12.02% |
| Asset Turnover | 1.82x |
| Receivables Turnover | 5.28x |
Taxes
Income tax took 31.20% of pretax income over the last 12 months.
| Income Tax (TTM) | $41.27M |
|---|---|
| Effective Tax Rate | 31.20% |
Scores
PGNY has an Altman Z-Score of 10.02, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 10.02 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.34B over the last 12 months is up 5.52% from the 12 months before.
| Revenue | $1.34B |
|---|---|
| Revenue Growth (YoY) | +5.52% |
| Gross Profit | $332.99M |
| Operating Income | $125.79M |
| Pretax Income | $132.29M |
| Net Income | $91.02M |
| EBITDA | $138.91M |
| EBIT | $132.29M |
| Reported EPS (TTM) | $1.29 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 61.27% of the $675.79M in total assets.
| Cash and Equivalents | $116.82M |
|---|---|
| Total Debt | $0 |
| Net Cash | $116.82M |
| Net Cash Per Share | $1.53 |
| Working Capital | $224.36M |
| Shareholder Equity | $414.03M |
| Book Value Per Share | $5.43 |
| Tangible Book Value | $388.67M |
| Tangible Book Per Share | $5.10 |
| Total Assets | $675.79M |
| Total Liabilities | $261.76M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $27.55M of capital spending, operating cash flow left $179.64M of free cash flow.
| Operating Cash Flow | $207.18M |
|---|---|
| Capital Expenditures | $27.55M |
| Free Cash Flow | $179.64M |
| FCF Per Share | $2.34 |
| Depreciation and Amortization | $6.62M |
| Share Repurchases | $313.06M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 9.40%, against a 5-year average of 5.51%.
| Gross Margin | 24.87% |
|---|---|
| Operating Margin | 9.40% |
| Pretax Margin | 9.88% |
| Net Margin | 6.80% |
| EBITDA Margin | 10.38% |
| EBIT Margin | 9.88% |
| FCF Margin | 13.42% |
| Gross Margin (5Y Average) | 22.19% |
| Operating Margin (5Y Average) | 5.51% |
| Net Margin (5Y Average) | 6.38% |
Growth
Revenue grew 17.87% a year over 3 years, and EPS 61.34% a year.
| Revenue Growth (3Y CAGR) | +17.87% |
|---|---|
| Revenue Growth (5Y CAGR) | +30.17% |
| EPS Growth (3Y CAGR) | +61.34% |
| EPS Growth (5Y CAGR) | +60.04% |
| FCF Growth (3Y CAGR) | +35.46% |
| FCF Growth (5Y CAGR) | +40.39% |
| Operating Income Growth (3Y CAGR) | +54.02% |
| Book Value Per Share Growth (2Y CAGR) | +2.47% |
| Tangible Book Per Share Growth (2Y CAGR) | +0.93% |
Dividends and Yields
PGNY does not pay a dividend. Its free cash flow yield is 6.42%.
| Earnings Yield | 3.51% |
|---|---|
| FCF Yield | 6.42% |
| Buyback Yield | 11.14% |
| Shareholder Yield | 11.14% |
Peer Position
Against 10 similar companies, PGNY has the 8th highest P/E and the 4th highest P/S.
P/E RatioPeer median 48.1x
P/S RatioPeer median 0.8x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.08%
| P/E Ratio | 28.5x vs 48.1x median |
|---|---|
| P/S Ratio | 2.1x vs 0.8x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.52% vs +11.08% median |
Analyst Forecast
Consensus estimates put revenue growth at 9.33% and EPS growth at 38.09% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +9.33% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +38.09% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PGNY
What is PGNY's market cap?
Progyny has a market cap of $2.74B. Its enterprise value, which adds debt and subtracts cash, is $2.62B.
What is PGNY's P/E ratio?
Progyny has a trailing P/E ratio of 28.5x and a forward P/E of 28.0x.
How many shares of PGNY are outstanding?
Progyny has 76.23M shares outstanding. The count is down 11.38% from a year earlier.
Does PGNY pay a dividend?
No. Progyny does not pay a dividend.
How much debt does PGNY have?
Progyny has $0 of total debt and $116.82M of cash and equivalents, a net cash position of $116.82M.
PGNY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors